| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.034 | 0.8 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.9 |